Related Experiment Video
Updated: Feb 24, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Silencing of TGF-β1 in tumor cells impacts MMP-9 in tumor microenvironment
Lakisha D Moore-Smith1, Tatyana Isayeva1, Joo Hyoung Lee1
1Department of Pathology, The University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
Abstract:
Transforming growth factor (TGF)-β1 contributes to autocrine and paracrine functions in the tumor microenvironment (TME). The present study examined the effects of TGF-β1 crosstalk in TME and its role in mediating tumor formation and progression by targeted abrogation of TGF-β1 expression in metastatic cells in situ. Using species-specific primers, we found a significant increase in MMP-9 gene expression in the tumor-reactive stroma during late-stage metastasis in the lung. This effect was also confirmed in cancer-associated fibroblasts (CAFs) when co-cultured with the tumor cells. Knockdown of TGF-β1 expression in the tumor cells negatively affected matrix metalloproteinase (MMP)-9 gene expression. Fibroblasts, cultured in the presence of tumor cells with intact TGF-β1, showed a significant increase in proliferation rate, as well as expression of VEGF, bFGF, and SDF-1, which was not seen when TGF-β1 expression was abrogated in tumor cells. Absence of TGF-β1 in tumor cells also failed to result in myofibroblast differentiation. Co-implantation of CAFs and tumor cells with either intact TGF-β1 expression or devoid of TGF-β1 in vivo showed a significant increase in tumor growth kinetics in both cell types, suggesting a possible activation TGF-β receptor signaling in tumor cells in response to TGF-β from the TME.
Insights
Transforming growth factor-beta 1 (TGF-β1) drives tumor progression. Abrogating TGF-β1 in cancer cells reduced MMP-9 expression and fibroblast proliferation, impacting tumor growth.
Area of Science:
- Oncology
- Cell Biology
- Cancer Research
Background:
- Transforming growth factor-beta 1 (TGF-β1) plays a critical role in the tumor microenvironment (TME).
- TGF-β1 influences both autocrine and paracrine signaling pathways.
- Understanding TGF-β1's role is crucial for targeting tumor formation and progression.
Purpose of the Study:
- To investigate the effects of TGF-β1 crosstalk within the TME.
- To determine TGF-β1's role in mediating tumor formation and progression.
- To examine the impact of targeted TGF-β1 abrogation in metastatic cells.
Main Methods:
- Utilized species-specific primers to analyze gene expression.
- Conducted co-culture experiments with tumor cells and cancer-associated fibroblasts (CAFs).
- Performed in vivo co-implantation studies of CAFs and tumor cells with and without TGF-β1 expression.
Main Results:
- Significant increase in matrix metalloproteinase-9 (MMP-9) gene expression in tumor-reactive stroma during late-stage lung metastasis.
- Knockdown of TGF-β1 in tumor cells reduced MMP-9 gene expression.
- TGF-β1 from tumor cells significantly increased fibroblast proliferation and expression of VEGF, bFGF, and SDF-1, promoting tumor growth.
Conclusions:
- TGF-β1 signaling is a key mediator of tumor progression and TME modulation.
- Targeting TGF-β1 in tumor cells can inhibit pro-tumorigenic factors and fibroblast activation.
- Further investigation into TGF-β receptor signaling in tumor cells is warranted.
Related Concept Videos
The Tumor Microenvironment
TGF - β Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Role of Matrix Metalloproteases in Degradation of ECM
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

